Position
Chief Commercial Officer
Company
Beam Therapeutics Inc.
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsDescription
Beam Therapeutics has appointed Eric Foster as Chief Commercial Officer. With over 25 years of experience in biotechnology and specialty pharmaceuticals, Mr. Foster is set to play a crucial role in leading the company's commercial strategies as they prepare for future product launches.
Quick answer
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer (September 1, 2026). Beam Therapeutics Inc. is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Beam Therapeutics Inc?
- Beam Therapeutics Inc. named Eric Foster Chief Commercial Officer, announced September 1, 2026.
- What did Beam Therapeutics Inc. announce on September 1, 2026?
- Beam Therapeutics has appointed Eric Foster as Chief Commercial Officer. With over 25 years of experience in biotechnology and specialty pharmaceuticals, Mr. Foster is set to play a crucial role in leading the company's commercial strategies as they prepare for future product launches.
- What does Beam Therapeutics Inc. do?
- Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
- Where is Beam Therapeutics Inc. based?
- Beam Therapeutics Inc. is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Azora Therapeutics, Inc. (DE) (August 29, 2026), Parabilis Medicines (August 25, 2026), Oruka Therapeutics (August 24, 2026) and Retension Pharmaceuticals (September 10, 2026) also announced leadership changes within 45 days of Beam Therapeutics Inc.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Adial Pharmaceuticals Appoints Matthew Davidson as President and CEO (August 29, 2026)
- Parabilis Medicines Appoints Craig Tendler as Director (August 25, 2026)
- Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer (August 24, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
Who to call at Beam Therapeutics Inc., and when
A new leader at Beam Therapeutics Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Beam Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beam Therapeutics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beam Therapeutics Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beam Therapeutics Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Beam Therapeutics Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.